Altered Signaling at the PTH Receptor Via Modified Agonist Contacts with the Extracellular Domain Provides a Path to Prolonged Agonism in Vivo

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2022 Nov 21

PMID 36409914

Authors

Shi Liu

Zhen Yu

Eileen J Daley

Craig A Bingman

Austin T Bruchs

Thomas J Gardella

Samuel H Gellman

Affiliations

Soon will be listed here.

Abstract

The parathyroid hormone type 1 receptor (PTHR1), a Class B GPCR, is activated by long polypeptides, including drugs for osteoporosis and hypoparathyroidism. The PTHR1 engages peptide agonists via a two-step mechanism. Initial contact involves the extracellular domain (ECD), which has been thought to contribute primarily to receptor-peptide binding, and then the N terminus of the peptide engages the receptor transmembrane domain (TMD), which is thought to control the message conveyed to intracellular partners. This mechanism has been suggested to apply to other Class B GPCRs as well. Here, we show that modification of a PTHR1 agonist at ECD-contact sites can alter the signaling profile, an outcome that is not accommodated by the current two-step binding model. Our data support a modified two-step binding model in which agonist orientation on the ECD surface can influence the geometry of agonist-TMD engagement. This expanded binding model offers a mechanism by which altering ECD-contact residues can affect signaling profile. Our discoveries provide a rationale for exploring agonist modifications distal from the TMD-contact region in future efforts to optimize therapeutic performance of peptide hormone analogs.

Citing Articles

Highly biased agonism for GPCR ligands via nanobody tethering.

Sachdev S, Creemer B, Gardella T, Cheloha R Nat Commun. 2024; 15(1):4687.

PMID: 38824166 PMC: 11144202. DOI: 10.1038/s41467-024-49068-5.

A Natural Peptide from A Traditional Chinese Medicine Has the Potential to Treat Chronic Atrophic Gastritis by Activating Gastric Stem Cells.

Li K, Ma X, Li Z, Liu Y, Shen G, Luo Z Adv Sci (Weinh). 2024; 11(20):e2304326.

PMID: 38544338 PMC: 11132046. DOI: 10.1002/advs.202304326.

Backbone Modification Provides a Long-Acting Inverse Agonist of Pathogenic, Constitutively Active PTH1R Variants.

Liu S, Daley E, Tran L, Yu Z, Reyes M, Dean T J Am Chem Soc. 2024; 146(10):6522-6529.

PMID: 38417010 PMC: 11162201. DOI: 10.1021/jacs.3c09694.

Hormone Analogues with Unique Signaling Profiles from Replacement of α-Residue Triads with β/γ Diads.

Gibadullin R, Kim T, Tran L, Gellman S J Am Chem Soc. 2023; 145(37):20539-20550.

PMID: 37697685 PMC: 10588032. DOI: 10.1021/jacs.3c06703.

References

McGarvey J, Xiao K, Bowman S, Mamonova T, Zhang Q, Bisello A . Actin-Sorting Nexin 27 (SNX27)-Retromer Complex Mediates Rapid Parathyroid Hormone Receptor Recycling. J Biol Chem. 2016; 291(21):10986-1002. PMC: 4900250. DOI: 10.1074/jbc.M115.697045. View

Gardella T, Luck M, Wilson A, Keutmann H, Nussbaum S, Potts Jr J . Parathyroid hormone (PTH)-PTH-related peptide hybrid peptides reveal functional interactions between the 1-14 and 15-34 domains of the ligand. J Biol Chem. 1995; 270(12):6584-8. DOI: 10.1074/jbc.270.12.6584. View

White A, Pena K, Clark L, Santa Maria C, Liu S, Jean-Alphonse F . Spatial bias in cAMP generation determines biological responses to PTH type 1 receptor activation. Sci Signal. 2021; 14(703):eabc5944. PMC: 8682804. DOI: 10.1126/scisignal.abc5944. View

Hattersley G, Dean T, Corbin B, Bahar H, Gardella T . Binding Selectivity of Abaloparatide for PTH-Type-1-Receptor Conformations and Effects on Downstream Signaling. Endocrinology. 2015; 157(1):141-9. PMC: 4701881. DOI: 10.1210/en.2015-1726. View

Vilardaga J, Gardella T, Wehbi V, Feinstein T . Non-canonical signaling of the PTH receptor. Trends Pharmacol Sci. 2012; 33(8):423-31. PMC: 3428041. DOI: 10.1016/j.tips.2012.05.004. View

Kim E, Keating G . Recombinant Human Parathyroid Hormone (1-84): A Review in Hypoparathyroidism. Drugs. 2015; 75(11):1293-303. DOI: 10.1007/s40265-015-0438-2. View

Hollenstein K, de Graaf C, Bortolato A, Wang M, Marshall F, Stevens R . Insights into the structure of class B GPCRs. Trends Pharmacol Sci. 2013; 35(1):12-22. PMC: 3931419. DOI: 10.1016/j.tips.2013.11.001. View

Ma S, Shen Q, Zhao L, Mao C, Zhou X, Shen D . Molecular Basis for Hormone Recognition and Activation of Corticotropin-Releasing Factor Receptors. Mol Cell. 2020; 77(3):669-680.e4. DOI: 10.1016/j.molcel.2020.01.013. View

Liu S, Cheloha R, Watanabe T, Gardella T, Gellman S . Receptor selectivity from minimal backbone modification of a polypeptide agonist. Proc Natl Acad Sci U S A. 2018; 115(49):12383-12388. PMC: 6298075. DOI: 10.1073/pnas.1815294115. View

10.

Chi Y, English E, Pomerantz W, Seth Horne W, Joyce L, Alexander L . Practical synthesis of enantiomerically pure beta2-amino acids via proline-catalyzed diastereoselective aminomethylation of aldehydes. J Am Chem Soc. 2007; 129(18):6050-5. DOI: 10.1021/ja070063i. View

11.

Zhao L, Ma S, Sutkeviciute I, Shen D, Zhou X, de Waal P . Structure and dynamics of the active human parathyroid hormone receptor-1. Science. 2019; 364(6436):148-153. PMC: 6929210. DOI: 10.1126/science.aav7942. View

12.

Wang X, Cheng X, Zhao L, Wang Y, Ye C, Zou X . Molecular insights into differentiated ligand recognition of the human parathyroid hormone receptor 2. Proc Natl Acad Sci U S A. 2021; 118(32). PMC: 8364112. DOI: 10.1073/pnas.2101279118. View

13.

Vilardaga J, Jean-Alphonse F, Gardella T . Endosomal generation of cAMP in GPCR signaling. Nat Chem Biol. 2014; 10(9):700-6. PMC: 4417940. DOI: 10.1038/nchembio.1611. View

14.

Shimizu N, Guo J, Gardella T . Parathyroid hormone (PTH)-(1-14) and -(1-11) analogs conformationally constrained by alpha-aminoisobutyric acid mediate full agonist responses via the juxtamembrane region of the PTH-1 receptor. J Biol Chem. 2001; 276(52):49003-12. DOI: 10.1074/jbc.M106827200. View

15.

Liang Y, Khoshouei M, Radjainia M, Zhang Y, Glukhova A, Tarrasch J . Phase-plate cryo-EM structure of a class B GPCR-G-protein complex. Nature. 2017; 546(7656):118-123. PMC: 5832441. DOI: 10.1038/nature22327. View

16.

Karle I, Balaram P . Structural characteristics of alpha-helical peptide molecules containing Aib residues. Biochemistry. 1990; 29(29):6747-56. DOI: 10.1021/bi00481a001. View

17.

Castro M, Nikolaev V, Palm D, Lohse M, Vilardaga J . Turn-on switch in parathyroid hormone receptor by a two-step parathyroid hormone binding mechanism. Proc Natl Acad Sci U S A. 2005; 102(44):16084-9. PMC: 1276049. DOI: 10.1073/pnas.0503942102. View

18.

Seth Horne W, Johnson L, Ketas T, Klasse P, Lu M, Moore J . Structural and biological mimicry of protein surface recognition by alpha/beta-peptide foldamers. Proc Natl Acad Sci U S A. 2009; 106(35):14751-6. PMC: 2736470. DOI: 10.1073/pnas.0902663106. View

19.

Liu S, Jean-Alphonse F, White A, Wootten D, Sexton P, Gardella T . Use of Backbone Modification To Enlarge the Spatiotemporal Diversity of Parathyroid Hormone Receptor-1 Signaling via Biased Agonism. J Am Chem Soc. 2019; 141(37):14486-14490. PMC: 6930011. DOI: 10.1021/jacs.9b04179. View

20.

Cheloha R, Chen B, Kumar N, Watanabe T, Thorne R, Li L . Development of Potent, Protease-Resistant Agonists of the Parathyroid Hormone Receptor with Broad β Residue Distribution. J Med Chem. 2017; 60(21):8816-8833. PMC: 6016400. DOI: 10.1021/acs.jmedchem.7b00876. View